Conditions: Squamous Cell Carcinoma
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 35
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine the safety and tolerability of pharmaceutical compound 31510 in a topical cream when applied to in situ cutaneous squamous cell carcinoma and to obtain preliminary efficacy data for the treatment of in situ cutaneous squamous cell carcinoma by Compound 31510 topical cream.

Detailed description:

Arms:
arm 1: Active Cream 3%; AM \& PM

Interventions: intervention 1: API 31510
Intervention descriptions: intervention 1: Topical Cream; 3% active; AM \& PM application

Protocol document: